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Summary 
HIV-1 sero-discordant couples are at risk of transmitting to each other HIV, HBV and HCV. This cross-sectional 
study evaluated the prevalence of HBV and HCV infection and associated risk factors among 270 heterosexual HIV 
sero-discordant couples. Serum samples and data from questionnaires at baseline were obtained from the Phase 
III randomized placebo-controlled trial of acyclovir for Herpes Simplex Virus-2 suppression to prevent HIV 
transmission among HIV sero-discordant couples site in Kisumu. The serum samples were analyzed for Hepatitis 
B surface antigen, antibodies to Hepatitis B core antigen and HCV IgG antibodies. The prevalence of HBV and 
HCV was not associated with age, gender, income, education, number of children or years lived together and use 
of contraception. Regardless of whether the participants were HIV positive or not, HCV and HBV prevalence rates 
were 4%, 5.6% respectively, and HBV/HCV co-infection rate was 0.2%. HCV prevalence was associated with the 
HIV-1 infection. Since the prevalence of HBV was high, HBV prevention measures should be encouraged among 
HIV-1 sero-discordant couples to reduce HBV transmission rates among couples. All HIV-1 positive patients 
should be tested for both HBV and HCV, since HIV positive patients are likely to have HBV or HCV co-infection. 
 
[Afr J Health Sci. 2016; 29(1):54-67]  
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Introduction 
There are about 338,000 HIV-1 sero-discordant couples 
reported in Kenya [1]. Infection with HCV and HBV is 
common among HIV infected persons due to their shared 
modes of transmission [2, 3, 7, 8] and this represents an 
increasingly important public health problem [2]. Partners 
in HIV-1 sero-discordant couples are at risk of 
transmitting to each other STIs such as HBV and HCV 
which are common in HIV infected patients. 
HIV-negative individuals in sero-discordant relationships 
may be at increased risk of HIV sero-conversion 
following infection with other STIs including HCV and 
HBV [14].  
HIV positive individuals with chronic HBV and HCV co-
infection tend to experience more rapid liver disease 
progression than HIV negative people [15] and treatment 
of viral hepatitis due to dual HBV/HCV infection 
represents a challenge [16]. Hepatitis C may affect the 
course and management of HIV infection [17].  
Although infection with HCV and HBV is common among 
HIV-infected persons, their prevalence, risk factors and 
relationship to HIV infection are not well characterized 
among HIV-discordant couples in Kenya. As a result, our 
study sought to evaluate the potential risk factors 
associated with coinfections and establish the prevalence 
of HCV and HBV among HIV sero-discordant couples in 
Kisumu, Siaya, Busia, Vihiga and Migori counties in 
Kenya. 
Materials and Methods 
Study design 
The study participants were recruited from Kisumu, 
Siaya, Busia, Vihiga and Migori counties in Kenya [18, 
19]. This was a cross-sectional measurement of 
antibodies to HCV, HBsAg and sexual behaviors in HIV 
sero-discordant couples. This study was nested within a 
completed Phase III randomized placebo-controlled trial 
of acyclovir for HSV-2 suppression to prevent HIV 
transmission among HIV sero-discordant couples in 
Kenya [18, 19]. Serum samples and data from completed 
epidemiological questionnaires were obtained from the 
completed study. A sample size of 270 couples was 
expected to achieve the required sufficient precision for 
the estimated prevalence of HCV and HBV in HIV 
discordant couples. Two hundred and seventy couples 
whose sexual behavior information was complete in the 
questionnaires and serum samples were adequate were 
randomly selected from the pool of 530 HIV sero-
discordant couples in the completed parent study. 
Enrollment 
Details on recruitment criteria of HIV-1 sero-discordant 
heterosexual couples for the completed parent study 
have been described in other published papers [18, 19, 
20]. Briefly, the study population consisted of 
heterosexual HIV sero-discordant couples in which the 
HIV-infected partner had a CD4 cell count of at least 
250 cells/mm3 at enrolment. In this study, heterosexual 
couples were defined as sexual partners of the opposite 
gender who are married, have been living together, or 
otherwise considered each other a primary partner. In 
addition, one partner (index participant) in the couple was 
infected with both HIV and HSV-2, while the partner 
participant was not infected with either HIV or HSV-2 at 
baseline. To focus on sex-related exposures, participants 
who reported blood transfusion, surgery or injection drug 
uses were excluded during analysis. 
Blood sample collection and processing 
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Venous blood (57.5ml) for use in this study was drawn 
from the participants by venipuncture and collected into 
anticoagulant vacutainers blood collection tubes. Serum 
was harvested following centrifugation at 1500 
revolutions per 5 minutes. All samples were appropriately 
labeled with the participants study identification numbers 
(PID) and stored in -80°C freezers in KEMRI-CUSF 
laboratories in Kisumu, Kenya until required for use. 
Laboratory testing 
All laboratory tests were conducted at the Kenya National 
Blood Transfusion Services (KNBTS). HBsAg and anti-
HCV antibody testing was conducted on coded frozen 
serum samples from each participant using third 
generation HBV and HCV ELISAs. Murex HBsAg version 
3 [21] and Murex Anti-HCV version 4 [22] were used for 
the detection of Hepatitis B surface antigen (HBsAg) and 
anti-HCV IgG antibodies respectively. All positive 
samples were retested in duplicate to rule out false 
positive cases.  
Samples that were positive for HBsAg and anti-HCV IgG 
antibodies were confirmed by using the ANILAB 
SYSTEMS HBsAg EIA PLUS kit [23] and HUMAN anti-
HCV kit [24] respectively.  
HBsAg reactive samples were tested further for antibody 
to Hepatitis B core antigen (anti-HBc-IgG/IgM) using 
DRG Diagnostics Anti HBC ELISA [25], to discriminate 
possible window phase HBV cases from chronic carrier 
cases. Window phase cases were defined as samples 
that tested negative for anti-HBc-IgG/IgM, while chronic 
carrier cases were defined as samples that tested 
positive for anti-HBc-IgG/IgM. 
Data collection  
Demographic, behavioral and clinical data were collected 
from enrolled participants through interviewer-
administered questions [19]. Data forms were scanned 
and entered using intelligent character recognition  
DataFax software (DataFax, ver 3.7-004, Clinical 
DataFax Systems Inc., Hamilton, Ontario, Canada) and 
centrally double-verified by independent data technicians 
[19]. 
Data analysis  
STATA statistical software was used for analyzing the 
data. Chi-square and logistic regression were used to 
test whether there was any association between HCV 
and HBV infection status and sexual behaviors in HIV 
sero-discordant couples and P<0.05 was considered as 
having significant association. 
Ethics Statement 
The current study protocol was also approved by the 
ethical committees of JKUAT, KEMRI and the Ancillary 
Study Committee of University of Washington, USA as 
part of the requirements for using samples and data from 
the completed parent study. Written informed consent 
was obtained prior to enrollment of study participants in 
the completed parent study [19]. The participants were 
asked to consent to the completed study and other 
ancillary study in the future on stored specimens. 
Results 
Demographic Characteristics of Enrolled Couples by 
Gender of HIV-infected Partner 
The baseline demographic characteristics of the couples 
by gender of HIV infected partner are shown in Table 1. 
In 154 couples studied, males were on average about 
older than their wives (p<0.0001). There was a tendency 
for more men to have more years of education than their 
 African Journal of Health Sciences, Volume 29, Number 1, January-February 2016 57 
wives (p<0.0001). More men than women had a source of income (p<0.0001).  
Table 1: Baseline Demographic Characteristics of Enrolled Couples by Gender of HIV-1 infected Partner 
  Couples in Whom Male is HIV+ Couples in Whom Female is HIV+ 
  HIV- (154) HIV+(154) p-value HIV-(116) HIV+(121*) p-value 
   Female Male    Male Female   
Age (mean(SD)) 28.89(7.87) 36.14(11.65) <0.0001 41.33(11.11) 32.58(9.41) <0.0001 
Married; (count (%))           
yes 145(94.2) 144(93.5) * 0.452 115(99.1)  120(99.2)** 0.976 
no 9(5.8) 10(6.5)   1(0.9) 1(0.8)   
Years of education; 
(count (%))           
None 5(3.3) 2(1.3)   1(0.9) 6(5.0)   
1-8y 111(72.1) 77(50.0) <0.0001 62(53.2) 94(77.6) <0.0001 
9-12y 32(20.8) 57(37.0)   46(39.7) 19(15.7)   
>12y 6(3.9) 18(11.7)   7(6.0) 2(1.7)   
Years lived together           
<=5y 87(60) 88(60.3)   41(36.6) 47(39.2)   
6-10y 35(24.1) 30(20.6)   27(24.1) 24(20.0)   
11-15y 12(8.3) 15(10.3) 0.619 17(15.2) 16(13.3) 0.918 
16-20y 5(3.5) 6(4.1)   8(7.1) 10(8.3)   
21-25y 6(4.2) 7(4.8)   19(17.0) 23(19.2)   
Total Number of Children           
None 22(14.3) 19(12.4)   4(3.5) 5(4.1)   
1-2. 77(50) 61(39.6) <0.0001 32(27.6) 39(32.2)   
3-4. 41(26.6) 34(22.1)   34(29.3) 40(33.1) 0.540 
>=5 14(9.1) 40(26.0)   46(39.7) 37(30.6)   
Total number of children 
with study partner           
None 45(29.2) 48(31.2)   14(12.1) 17(14.1)   
1-2. 66(42.9) 67(43.5) 0.622 34(29.3) 37(30.6)   
3-4. 32(20.8) 28(18.2)   36(31.0) 36(29.8) 0.955 
>=5 11(7.1) 11(7.1)   32(27.6) 31(25.6)   
Earns Income           
yes 24(15.6) 73(47.4) <0.0001 46(39.6) 6(5.0) <0.0001 
no 130(84.2) 81(52.6)   70(60.3) 115(95.0)   
* There is one couple at least where one partner (man) considers he is not married   while the partner (woman) believes she is married.  
**Five of the 116 HIV negative men had two wives resulting in 121 women. In five couples where the man had two wives, these were considered as two 
couples for each wife. 
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Sero-prevalence rates of HBV and HCV by Couple HIV status 
Results of testing for HBV and HCV viral markers by Couple HIV status are shown in Table 2 and Figures 1 and 2.  
Table 2: Prevalence of HBV, HCV by Couple HIV Status (Unit of analysis is couple) 
Status Couples with HIV+ Male Couples with HIV+ women 
  HIV- 
female  
HIV+ Male p-
value 
HIV- Male HIV+ 
Female 
p-
value  (No. of couples (%)) (No. of couples (%)) 
HBsAg          
        Negative 144(93.5) 137(89.0) 0.158 97(83.6) 113(93.4) 0.018 
        Positive 10(6.5) 17(11.0)   29(16.4) 8(6.11)   
Anti-HBc            
        Negative 150(97.4) 141(91.6) 0.03 103(88.8) 120(99.2) 0.001 
        Positive 4(2.6) 13(8.4)   13(11.2) 1(0.8)   
Anti-HCV            
        Negative 117(76.5) 134(87.97) 0.011 93(81.6) 98(83.4) 0.878 
        Positive 36(23.5) 19(12.4)   21(18.4) 21(17.7)   
Couples in whom the male is HIV-1 positive  
Among couples in whom the man is infected with HIV, 
there were no significant differences in prevalence’s of 
Hepatitis B Virus surface antigen (HBsAg) among the 
men 10(6.5%) compared to women 17(11%) (p=0.158). 
As for Hepatitis B core antibody (anti-HBc-IgG/IgM 
Antibodies), about 13(8.4%) of the men compared to 
4(2.6%) of the women tested positive for anti-HBc 
(p=0.03). More women 36(23.5%) than men 19(12.4%) 
tested positive for anti-HCV antibodies (p=0.011).  
Couples in whom the female is HIV-1 positive  
Among couples in whom the female was HIV+, there 
were significant differences with more men, 29(16.4%) 
than women 8(6.11%) testing positive for HBsAg 
(p=0.018) and more men 13(11.2%) than women 1 
(0.8%) testing positive for anti-HBc-IgG/IgM Antibodies, 
(p=0.001).  There were no significant differences in the 
prevalence of anti-HCV antibodies between men 
21(18.4%) and women 21(17.7%) in this group 
(p=0.878).  
Figure 1: Prevalence of HBsAg by Couples HIV Status. 
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 Figure 2: Prevalence of anti-HCV by Couple HIV Status    
 
HBV and HCV Co-infections 
HBV and HCV Co-infections in HIV-1 discordant couples 
Mono-infection as used in this study means infection with 
only one virus either HBV or HCV regardless of whether 
the study participant is HIV positive or not, and co-
infection means infection with both HBV and HCV 
regardless of whether the study participant  is HIV 
positive or not. 
Among HIV-1 discordant couples, 90.2% of the couples 
did not have HBV or HCV infection, 4.02% had HCV 
mono-infection, 5.62% had HBV mono-infection and 
0.16% had HCV and HBV co-infection (Figure 3).   
 
  Figure 3: Frequency of HBV and HCV Co-infections in HIV-1 Discordant couples 
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Analysis of Sexual risk factors for HBV and HCV 
infection among HIV- Discordant couples 
Sexual behaviors - birth control methods in women 
with HCV or HBV 
Regardless of their HIV status, there were no significant 
differences in the sexual behaviors - birth control 
methods (oral pills, intrauterine devices (IUDs), 
injectables, implants and condoms) between women with 
HCV or HBV. All sexual behaviors analyzed in this study 
were not associated with infection with HBV or HCV 
(Table 3). Other sexual behaviors were not analyzed due 
to few study participants reporting such behaviors in our 
study.  
 
Table 3: Sexual behaviors among women, Birth Control Methods 
 Women  
  HBV- and HCV- HBV+/HCV+ p-value  
Contraceptive use    
No 93(37.5) 23(27.71) 0.106 
Yes 155(62.5) 60(72.29)  
Oral    
No 246(99.19) 83(100) NA 
Yes 2(0.81) 0(0)  
IUD    
No 248(100) 83(100) NA 
Yes 0(0) 0(0)  
Injectables   0.826 
No 222(89.52) 75(90.36)  
Yes 26(10.48) 8(9.64)  
Implant   0.314 
No 245(98.79) 83(100)  
Yes 3(1.21) 0(0)  
Condom    
No 199(80.24) 72(86.75) 0.183 
Yes 49(19.76) 11(13.25)   
 
Analysis of Predictors for HBV infection among HIV-1 Discordant Couples 
Results of univariate and multivariate analysis of predictors of HBV infection among HIV-1 discordant couples are shown in 
Table 4. 
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Table 4: Univariate and Multivariate Analysis of Predictors of HBV infection among HIV-1 discordant Couples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Baseline category 
 
Univariate Analysis of Predictors of HBV infection 
among HIV-1 Discordant Couples 
In a HIV-1 discordant couple, the age gap between the 
two partners, a partner not earning income, an educated 
partner and living with partner, the number of children 
with study partner and the HIV-1 status of partner being 
positive were not significantly associated with HBV 
infection. Only being male was significantly associated 
with HBV infection at p=0.013, regardless of HIV status 
of self or partner. 
 
 
Covariate 
Univariate Analysis Multivariate Analysis 
OR p 95%CI OR p 95%CI 
Age 1.012 0.542 0.973 - 1.052 0.985 0.659 (0.921-1.053) 
Gender       
female* 1[Reference]   1[Reference]   
male 1.99 0.013 (1.159-3.417) 2.679 0.071 (0.919-7.812) 
Earns Income       
yes* 1[Reference]   1[Reference]   
no 0.837 0.554 (0.463-1.510) 2.027 0.292 (0.545-7.539) 
Education Years       
None* 1[Reference]   1[Reference]   
1-8y 0.756 0.721 (0.162-3.518 0.732 0.786 (0.078-6.915) 
9-12y 1.074 0.928  (0.229 - 
5.046 
1.424 0.773 (0.129-15.725) 
>12y 1.000 1  (0169 - 5.904    
Years lived 
together 
      
1y* 1[Reference]   1[Reference]   
2-5y 2.303 0.076 (0.916-5.788) 0.999 0.789 0.456 - 3.674 
>5y 1.723 0.233 (0.704-4.216) 3.637 0.131 (0.682-19.396) 
No. Children       
None* 1[Reference]      
1-2. 0.527 0.15 (0.220-1.260)    
3-4. 0.81 0.639 (0.337-1.950)    
>=5 0.496 0.149 (0.192-1.284)    
HIV Status       
HIV-* 1[Reference]   1[Reference]   
HIV+ 0.787 0.382 (0.460-1.346) 1.32 0.451 (0.641-2.721) 
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Multivariate Analysis of Predictors of HBV infection 
among HIV-1 Discordant Couples 
In a HIV-1 discordant couple, the age gap between the 
two partners, being male, a partner not earning income, 
an educated partner and living with partner and the HIV-
1 status of partner being positive were not significantly 
associated with HBV infection.  
Although being male (regardless of HIV status of self or 
partner), was significantly associated with HBV infection 
in univariate analysis (p=0.013), multivariate analysis 
showed no significant association (p=0.071). Therefore, 
in a HIV-1 discordant couple, the prevalence of HBV is 
not associated with the age gap between the two 
partners, the gender of the partners, a partner not 
earning income, the number of years of education of 
partners, the number of years lived together as a couple, 
the number of children had with partner and the HIV-1 
status of partner. 
 
Analysis of Predictors for HCV infection among HIV-
1 Discordant Couples 
Results of univariate and multivariate analysis of 
predictors of HCV infection among HIV-1 discordant 
couples are shown in Table 5.  
Table 5: Univariate and Multivariate Analysis of Predictors of HCV infection among HIV-1 Discordant Couples 
Covariate 
Univariate Analysis Multivariate Analysis 
OR p 95%CI OR p 95%CI 
Age 0.969 0.072 (0.935-1.003) 0.984 0.611 (0.927-1.046) 
Gender           
female* 1[Reference]   1[Reference]   
male 0.665 0.06 (0.434-1.017) 0.795 0.597 (0.340-1.858) 
Earns Income           
yes* 1[Reference]   1[Reference]   
no 1.344 0.264 (0.800-2.259) 1.093 0.865 (0.393-3.038) 
Education Years           
None* 1[Reference]   1[Reference]   
1-8y 1.396 0.664 (0.309-6.301) 2.282 0.477 (0.235-22.109) 
9-12y 1.286 0.752 (0.270-6.118) 1.246 0.852 (0.123-12.674) 
>12y 0.828 0.839 (0.134-5.113) 4.668 0.238 (0.361-60.416) 
Years lived together           
1y* 1[Reference]   1[Reference]   
2-5y 1.619 0.169 (0.815-3.214) 3.101 0.072 (0.905-10.627) 
>5y 1.214 0.573 (0.618-2.385) 1.937 0.356 (0.476-7.881) 
No. Children           
None* 1[Reference]   1[Reference]   
1-2. 1.204 0.686 (0.489-2.965) 0.267 0.06 (0.068-1.058) 
3-4. 1.815 0.198 (0.732-4.504) 0.482 0.39 (0.091-2.545) 
>=5 0.555 0.266 (0.197-1.566) 0.277 0.196 (0.040-1.941) 
HIV Status           
HIV-* 1[Reference]   1[Reference]   
HIV+ 0.635 0.037 (0.415-0.972) 0.416 0.028 (0.191-0.909) 
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* Baseline category 
 
Univariate Analysis of Predictors of HCV infection 
among HIV-1 Discordant Couples 
In a HIV-1 discordant couple, the age gap between the 
two partners, being male, a partner not earning an 
income, an educated partner, living with partner and the 
number of children with partner were not significantly 
associated with HCV infection.  
In a HIV-1 discordant couple, the HIV-1 status of partner 
being positive was significantly associated with HCV 
infection at p=0.037.  
 
Multivariate Analysis of Predictors of HCV infection 
among HIV-1 Discordant Couples 
In a HIV-1 discordant couple, the age gap between the 
two partners, being male, a partner not earning an 
income, number of years of education of partner, living 
with partner and number of children had with partner 
were not significantly associated with HCV infection. 
In a HIV-1 discordant couple, the HIV-1 status of partner 
being positive was significantly associated with HCV 
infection at p=0.028.  
Therefore, in a HIV-1 discordant couple, the prevalence 
of HCV is associated with HIV-1 status of partner being 
positive, but not the age gap between the two partners, 
the gender of the partners, a partner not earning an 
income, the number of years of education of partners, the 
number of years lived together as a couple and the 
number of children had with partner. 
 
Discussion 
Our study results observed that the prevalence of HBV 
and HCV was high among HIV-1 sero-discordant 
couples. The prevalence of HBV in HIV-1 sero-
discordant couples is not associated with the HIV-1 
status of partners and the prevalence of HCV in HIV-1 
sero-discordant couples is associated with the HIV-1 
status of partners. This cross-sectional study was 
conducted based on the need to establish the prevalence 
and potential risk factors of HCV and HBV among HIV-1 
sero-discordant couples since these are not well 
characterized in Kenya.  
In this study, regardless of the HIV status of the partners, 
the prevalence rate of HBV and HCV mono-infection, 
and HBV and HCV co-infection among HIV-1 discordant 
couples was 5.6%, 4% and 0.2% respectively. Our 
results are consistent with other studies where 
prevalence of HBV is expected to be high since HBV is 
endemic in  sub  Saharan Africa and the prevalence of 
HCV is expected to be less than 5%  due to low 
presence of high risk factors for HCV such as unsafe 
blood transfusions, intravenous drugs and homosexuality 
[9, 10, 11, 12, 13]. In a study conducted in Kisumu 
Kenya, 53% of the patients presenting with jaundice had 
HBV and HIV co-infection [26]. In Kenya, the prevalence 
rate of HCV and other risk factors for transmission of 
HCV and HIV among HIV/AIDS medical in-patients was 
low at 3.7% [27]. In other studies the prevalence of HBV 
and HCV co-infection among HIV-1 sero-discordant 
couples was between 0.3% to 1.5% [28, 29, 30]. 
The prevalence of HBV infection in our study participants 
was high but not associated with HIV status of partners, 
suggesting that partners in HIV-1 sero-discordant 
couples are likely to be infected with HBV since its 
endemic in the region [5, 6, 31, 32], but not as a result 
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of HIV infection.  This was also consistent with the 
assumption that in Sub-Saharan Africa, association 
between HBV with HIV is not expected to be strong since 
HBV is endemic in this region, and most sexually active 
adolescents and adults in this region have already been 
exposed to HBV before being exposed to HIV [5, 6, 31, 
32].  
The rate of HBV and HCV co-infection is generally low 
as confirmed by the results of our study and as well as 
other studies where the prevalence of HBV and HCV co-
infection among HIV-1 sero-discordant couples was 
between 0.3% to 1.5% [28, 29, 30]. It has also been 
observed in other studies, that prevalence of triple 
infection with HIV, HBV and HCV among HIV positive 
inpatients, outpatients and injecting drug users is usually 
low [29, 37]. This proves that since the three viruses 
share the same modes of transmission, co-infection with 
the three viruses is not uncommon, especially in HBV 
and HCV endemic areas and among people at high risk 
for parenteral infection [5, 6, 16]. Therefore, due to dual 
HBV/HCV infection, partners in HIV-1 sero-discordant 
couples are at risk of more severe liver disease, and are 
at an increased risk for progression to hepatocellular 
carcinoma and treatment of viral hepatitis will represent a 
challenge [15, 16]. Although, our studies results reported 
low HBV and HCV coinfection, prevention measures to 
reduce the risk factors that increase the chances of 
transmission of HCV/HBV among partners in HIV-1 
sero-discordant couples should still be advocated. 
Our study confirmed the presence of persistent chronic 
HBV infection among HIV-1 patients especially men 
(84%) and this has also been evident in other studies in 
Kenya [26]. Therefore, this implies that people who test 
positive for HBsAg and anti-HBc in a HIV-1 sero-
discordant couple pose as a source of infection to their 
partner. Consequently, men in HIV-1 discordant couples 
are more prone to be chronic carriers of HBV infection 
compared to women. 
Our study was able to prove that the following risk factors 
were not associated with the presence of HCV or HBV 
infection among HIV sero-discordant couples; age, 
gender, income, education, number of children or years 
lived together and use of barrier and non-barrier 
contraceptives by women. Only the HIV-1 status of a 
partner being positive was associated with the presence 
of HCV infection in the study group.  
 
 Conclusion 
The prevalence of HBV and HCV was high among HIV-1 
sero-discordant couples regardless of HIV status of 
partners. 
The prevalence of HBV and HCV in HIV-1 sero-
discordant couples was not associated with any of the 
following factors: age, gender, income, education, 
number of children or years lived together and use of 
barrier and non-barrier contraceptives.  
The prevalence of HBV in HIV-1 sero-discordant 
couples was not associated with the HIV-1 status of a 
partner being positive and the prevalence of HCV in HIV-
1 sero-discordant couples was associated with the HIV-
1 status of a partner being positive. 
Results of this study have clearly demonstrated that HBV 
prevention measures should be encouraged among HIV-
1 sero-discordant couples to reduce transmission of HBV 
and other STIs including HIV. All HIV-1 positive patients 
should be tested for both HBV and HCV, since HIV 
positive patients are likely to have HBV or HCV co-
infection. 
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